Figure 2 - uploaded by Ye Yi
Content may be subject to copyright.
Worldwide distribution of COVID-19 cases on 26 Feb. 2020, according to a coronavirus monitoring system of Johns Hopkins University [9,10].

Worldwide distribution of COVID-19 cases on 26 Feb. 2020, according to a coronavirus monitoring system of Johns Hopkins University [9,10].

Source publication
Article
Full-text available
The outbreak of Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has thus far killed over 3,000 people and infected over 80,000 in China and elsewhere in the world, resulting in catastrophe for humans. Similar to its homologous virus, SARS-CoV, which caused SARS in thousands of peop...

Contexts in source publication

Context 1
... cases, only 21 had direct contact with the Wuhan seafood market that was considered the starting site of the infection from an unknown animal source [6]. On January 30, WHO declared the outbreak a global health emergency. By the time of this report, the disease has already spread throughout China and near 50 other countries all over the world (Fig. 2). As the situation is rapidly evolving, the final scope and severity of the outbreak remain to be determined. On February 11, 2020, a multi-center study on 8,866 patients including 4,021 confirmed COVID-19 patients presented a more updated illustration of the epidemic as follows (https://mp.weixin.qq.com/s/ ...
Context 2
... cases, only 21 had direct contact with the Wuhan seafood market that was considered the starting site of the infection from an unknown animal source [6]. On January 30, WHO declared the outbreak a global health emergency. By the time of this report, the disease has already spread throughout China and near 50 other countries all over the world (Fig. 2). As the situation is rapidly evolving, the final scope and severity of the outbreak remain to be determined. On February 11, 2020, a multi-center study on 8,866 patients including 4,021 confirmed COVID-19 patients presented a more updated illustration of the epidemic as follows (https://mp.weixin.qq.com/s/ ...

Similar publications

Article
Full-text available
A novel SARS-like coronavirus (SARS-CoV-2) recently emerged and is rapidly spreading in humans1,2. A key to tackling this epidemic is to understand the virus’s receptor recognition mechanism, which regulates its infectivity, pathogenesis and host range. SARS-CoV-2 and SARS-CoV recognize the same receptor - human ACE2 (hACE2)3,4. Here we determined...
Preprint
COVID-19 is a recently emerged coronavirus which binds angiotensin-converting enzyme 2 (ACE2) for cell entry via its receptor binding domain (RBD) on a surface-expressed spike glycoprotein. Recent studies show that despite its similarities to severe acute respiratory syndrome (SARS) coronavirus, there are critical differences in key RBD residues wh...

Citations

... The SARS-CoV-2 pandemic has had a massive impact worldwide over the past two years, with over 620,000,000 infections and over 6,500,000 deaths as of October 2022 [1]. Patients with end-stage renal disease (ESRD) in renal replacement therapy, such as renal transplantation, peritoneal dialysis, and hemodialysis, are a population with higher infection rates and adverse outcomes, including hospitalizations, requirements of mechanical ventilation and deaths, compared to the general population [2][3][4][5]. ...
Article
Full-text available
End-stage renal disease (ESRD) patients are a population with high rates of COVID-19 and mortality. These patients present a low response to anti-SARS-CoV-2 immunization, which is associated with immune dysfunction. ESRD patients also present high plasma titers of Fibroblast Growth Factor 23 (FGF23), a protein hormone that reduces immune response in vivo and in vitro. Increased FGF23 levels associate with higher infection-related hospitalizations and adverse infectious outcomes. Thus, we evaluated whether ESRD patients with high FGF23 titers have an increased rate of SARS-CoV-2 infection. Methods: We performed a prospective cohort of ESRD patients in hemodialysis who had measurements of plasma intact FGF23 in 2019. We determined COVID-19 infections, hospitalizations, and mortality between January 2020 and December 2021. Results: We evaluated 243 patients. Age: 60.4 ± 10.8 years. Female: 120 (49.3%), diabetes: 110 (45.2%). During follow-up, 45 patients developed COVID-19 (18.5%), 35 patients were hospitalized, and 12 patients died (mortality rate: 26.6%). We found that patients with higher FGF23 levels (defined as equal or above median) had a higher rate of SARS-CoV-2 infection versus those with lower levels (18.8% versus 9.9%; Hazard ratio: 1.92 [1.03–3.56], p = 0.039). Multivariate analysis showed that increased plasma FGF23 was independently associated with SARS-CoV-2 infection and severe COVID-19. Discussion: Our results suggest that high plasma FGF23 levels are a risk factor for developing COVID-19 in ESRD patients. These data support the potential immunosuppressive effects of high circulating FGF23 as a factor implicated in the association with worse clinical outcomes. Further data are needed to confirm this hypothesis.
... Increased redox stress is known instigator of lung dysfunction (Kellner et al., 2017), cardiovascular disease (Dubois-Deruy et al., 2020), central nervous system dysfunction such as neurodegeneration and neuropsychiatric disease (Reiter, 1998;Patel, 2016;Salim, 2017) and the metabolic syndrome (Ando and Fujita, 2009;Roberts and Sindhu, 2009;Carrier, 2017) which are all manifestations of both acute severe COVID-19 and post-acute sequelae of SARS-CoV-2 infection (often called Long COVID syndrome; Figure 3; Nalbandian et al., 2021). Coronaviruses differ in their potential to induce end organ damage (Table 3; Bonavia et al., 1997;De Albuquerque et al., 2006;de Wilde et al., 2013;Josset et al., 2013;Zhao et al., 2015;Li et al., 2016;Agostini et al., 2018;Coperchini et al., 2020;Huang et al., 2020;Petersen et al., 2020;Wang et al., 2020;Yi et al., 2020;Caldera-Crespo et al., 2021;Paidas et al., 2021;Tian et al., 2021;Jansen et al., 2022). Among the various human coronaviruses, end organ damage is observed in MERS, SARS-CoV-1, and SARS-CoV-2. ...
... • Unlike MERS requires a TH17 type response (Yi et al., 2020) • Impacts the kidney (Jansen et al., 2022) similarly to MHV (De Albuquerque et al., 2006;Agostini et al., 2018;Caldera-Crespo et al., 2021;Paidas et al., 2021;Tian et al., 2021). ...
Article
Full-text available
Coronaviruses can cause serious respiratory tract infections and may also impact other end organs such as the central nervous system, the lung and the heart. The coronavirus disease 2019 (COVID-19) has had a devastating impact on humanity. Understanding the mechanisms that contribute to the pathogenesis of coronavirus infections, will set the foundation for development of new treatments to attenuate the impact of infections with coronaviruses on host cells and tissues. During infection of host cells, coronaviruses trigger an imbalance between increased production of reactive oxygen species (ROS) and reduced antioxidant host responses that leads to increased redox stress. Subsequently, increased redox stress contributes to reduced antiviral host responses and increased virus-induced inflammation and apoptosis that ultimately drive cell and tissue damage and end organ disease. However, there is limited understanding how different coronaviruses including SARS-CoV-2, manipulate cellular machinery that drives redox responses. This review aims to elucidate the redox mechanisms involved in the replication of coronaviruses and associated inflammation, apoptotic pathways, autoimmunity, vascular dysfunction and tissue damage that collectively contribute to multiorgan damage.
... The novel coronavirus (n-CoV) pandemic brought about a dramatic change worldwide within a quite short period. 1 Emerging from the city of Wuhan, China, this deadly disease has transformed into an extraordinary disaster toward global health, economy, and geopolitical scenario. 2 It is for the third time that the coronavirus family resulted in a pandemic, following Middle East respiratory syndrome (MERS) in 2012 3 and severe acute respiratory syndrome (SARS) in 2003. ...
... El virus denominado COVID-19 surgió en diciembre de 2019 en Wuhan, China, y debido a la movilidad internacional de las personas, hoy en día con mucha mayor facilidad que en otros momentos, este se propagó de forma rápida, tal que el 11 de marzo de 2020 (tan solo tres meses después de identificarlo), la Organización Mundial de la Salud (oms) declarara estado de emergencia sanitaria al considerar a la COVID-19 como pandemia global, "incluso fuertemente más poderosa que el terrorismo" (Ye et al., 2020(Ye et al., , p. 1753) así como el mayor desafío desde la Segunda Guerra Mundial (pnud, 2020, en Gutiérrez-Moreno, 2020. ...
Book
La pandemia por COVID-19 ha sido uno de los fenómenos más desestabilizadores, por su globalización y por su afectación en todas las áreas de la vida, al que la humanidad se ha enfrentado. Aunque vamos siendo conscientes paulatinamente de las problemáticas que han ido emergiendo a partir del fenómeno, es un hecho que todavía no vislumbramos a cabalidad los costos que tendremos que afrontar a largo plazo. Sin embargo, también es importante visualizar, reflexionar y ser conscientes de la otra cara de la moneda: la pandemia también nos ha enseñado y mostrado aspectos positivos y enriquecedores de nuestras cualidades humanas en múltiples aspectos. Este es el mensaje principal del presente libro, que integra las experiencias de profesionistas de diversas disciplinas que, desde sus muy particulares espacios (la investigación, la academia, la clínica) nos guían hacia la reflexión y el análisis de los desafíos, pero también de las oportunidades y retos que la pandemia por Covid-19 nos ha enseñado al día de hoy, así como a considerar las posibles implicaciones para nuestro futuro como individuos, sociedad y humanidad.
... In the beginning, snakes charged as an adapter host of SARS-CoV-2 transmission [11]. Later, pangolins were proposed as potential transitional hosts for SARS-CoV-2 as the genetic symmetry with CoVs in pangolins is high, and the difference is less than 1% [12]. The epidemiology of COVID-19 can be divided into three stages [13]. ...
Article
Full-text available
COVID-19 is a worldwide pandemic caused by SARS-coronavirus-2 (SARS-CoV-2). Less than a year after the emergence of the Covid-19 pandemic, many vaccines have arrived on the market with innovative technologies in the field of vaccinology. Based on the use of messenger RNA (mRNA) encoding the Spike SARS-Cov-2 protein or Abbreviations: ACE2, angiotensin-converting enzyme 2; BIBP, Beijing Institute of biological products; CD, cluster of differentiation; CDC, Centers for Disease 2 Variants Pandemic disease Vaccines on the use of recombinant adenovirus vectors enabling the gene encoding the Spike protein to be introduced into our cells, these strategies make it possible to envisage the vaccination in a new light with tools that are more scalable than the vaccine strategies used so far. Faced with the appearance of new variants, which will gradually take precedence over the strain at the origin of the pandemic, these new strategies will allow a much faster update of vaccines to fight against these new variants, some of which may escape neutralization by vaccine antibodies. However, only a vaccination policy based on rapid and massive vaccination of the population but requiring a supply of sufficient doses could make it possible to combat the emergence of these variants. Indeed, the greater the number of infected individuals, the faster the virus multiplies, with an increased risk of the emergence of variants in these RNA viruses. This review will discuss SARS-CoV-2 pathophysiology and evolution approaches in altered transmission platforms and emphasize the different mutations and how they influence the virus characteristics. Also, this article summarizes the common vaccines and the implication of the mutations and genetic variety of SARS-CoV-2 on the COVID-19 biomedical arbitrations.
... After internalization of virus by host cells, the subsequent clinical manifestations of infection include a spectrum of symptoms ranging from asymptomatic to acute respiratory distress syndrome (ARDS) (1,5). As a first line of defense against the virus, viral particles are recognized by pattern recognition receptors (PRR) by the host innate immune system including toll-like receptors (TLRs), which are expressed on immune cells and nonimmune cells, including airway and lung epithelial cells (6,7). ...
Preprint
Background: Signaling by toll like receptors (TLRs) initiates important immune responses against viral infection. The role of TLRs in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is not well elucidated. Thus, we investigated the interaction of TLRs agonists and SARS-COV-2 antigens with immune cells in vitro. Material & methods: 30 coronavirus disease 2019 (COVID-19) patients (15 severe and 15 moderate) and 10 age and sex matched control (HC) were enrolled. Peripheral blood mononuclear cells (PBMCs) were isolated and activated with TLR3, 7, 8 and 9 agonists, the spike protein (SP) of SARS-CoV-2 and the Receptor Binding Domain (RBD) unit of SP. Frequencies of CD3+IFN-β+ T cells, and CD3+IFN-g+ T cells was evaluated by flow cytometry. Interferon (IFN)-b gene expression was assessed by qRT-PCR. Results: The frequency of CD3+IFN-β+ T cells was higher in moderate and severe patients at baseline in comparison with HCs. Stimulation of PBMCs from moderate patients with SP and TLR8 agonist significantly upregulated the frequency of CD3+IFN-β+ T cells (P=0.0005 and 0.0024, respectively) when compared to non-stimulated (NS) samples. The greatest increase in CD3+IFN-b+ T cell frequency in PBMCs from severe patients was seen with TLR8 and TLR7 agonists when compared to NS (P= 0.003 and 0.0167, respectively). TLR stimulation did not significantly enhance the frequency of CD3+IFN-g+ T cells generated from PBMCs from moderate and severe patients compared with unstimulated controls. However, the frequency of CD3+IFN-ɣ+ T cells in PBMCs from moderate patients was upregulated by agonists of TLR3, 8 and 9, SP and RBD when compared with NS samples from HCs. The expression of the IFN-β gene after stimulation of CD3+T cells with the TLR8 agonist was also up-regulated in moderate than severe patients (moderate vs. severe: p=0.0006). In addition, stimulation of CD3+ T cells with SP, up-regulated the expression of IFN-β gene expression in cells from patients with moderate disease (moderate vs. severe: p=0.01). Conclusion: Stimulation of PBMCs from COVID-19 patients with a TLR8 agonist and with SP enhanced IFN-b protein and gene levels. This may potentiate immune responses against SARS-CoV-2 infection and prevent viral replication and spread.
... This occurrence, COVID-19, has exacerbated the widening gaps between those with and without in recent years. COVID-19 has worsened disparities between populations within nations (like low-income and marginalized groups) and between nations [74]. Many individuals will lack the resources essential to remain resilient in the face of this career setback. ...
Chapter
Full-text available
This chapter focuses on the exclusive and social experiences of people in post-COVID-19 life. As it can be observed from the current scenario how people have already accepted COVID-19 as a part of their daily routine. That is from wearing masks to using hand sanitizers and other precautionary activities. Based on these observable changes and adaptation of habits, the current chapter will delve into the psychological causes based on various theoretical concepts and the present literature on how humans use varied mechanisms to adapt to aversive situations and emerge by transforming themselves to be more resilient than before. Likewise, the chapter will also focus on individual and social strategies that can be employed to further strengthen the resilience of people post COVID-19.
... Langfristige Folgen sind dysregulierter Schlaf-Wach-Zyklus, kognitive Beeinträchtigung, Anhedonie, Distress und Anergie [256]. In den bislang vorliegenden schlafmedizinischen Untersuchungen zeigen sich insbesondere Insomnien [257]. Des Weiteren gibt es Hinweise auf REM-Phasen-assoziierte Schlafstörungen [258] als Ausdruck der zerebralen infektassoziierten Pathologie [259], jedoch liegen noch keine systematischen Untersuchungen vor. ...
Article
Full-text available
Zusammenfassung Die Deutsche Gesellschaft für Pneumologie hat 2021 die AWMF S1-Leitlinie Long-/Post-COVID initiiert. In einem breiten interdisziplinären Ansatz wurde diese S1-Leitlinie basierend auf dem aktuellen Wissensstand gestaltet. Die klinische Empfehlung beschreibt die aktuellen Long- bzw. Post-COVID-Symptome, diagnostische Ansätze und Therapien. Neben der allgemeinen und konsentierten Einführung wurde ein fachspezifischer Zugang gewählt, der den aktuellen Wissensstand zusammenfasst. Die Leitlinie hat einen explizit praktischen Anspruch und wird basierend auf dem aktuellen Wissenszugewinn vom Autorenteam weiterentwickelt und adaptiert.
... Fortunately, these seem to be reparable in primary school children. Our findings, in addition to other studies of the effects of specific COVID-19 mitigation measures [44][45][46][47], provide a basis for policymakers to target and mandate future virus-related mitigation measures in an evidence-based manner. ...
Preprint
Full-text available
Background: Previous studies have shown that coronavirus disease 2019 (COVID-19) mitigation measures lead to reductions in health status and health-related fitness in children, whereas no data are currently available on the development of children after the removal of these mitigation measures. Therefore, we aimed to investigate the influence of different stringent measures, during and after COVID-19, on the longitudinal development of fitness and health status of primary school children. METHODS: A longitudinal cohort study of 331 primary school children in Austria aged 7.7 (SD-0.4) years at the start of the observation period was conducted. Before (Sept 2019), and during (June 2020, Sept 2020) and after (March 2021, June 2021, Sept 2021, and June 2022) the COVID-19 mitigation measures, fitness tests were carried out and anthropometric data of the children were collected. Age- and sex-specific standard deviation scores (SDSs) were calculated for seven individual fitness tests of the AUT FIT [1] test battery, body mass index, and waist-to-height ratio. In addition, children were classified into different fitness categories based on the AUT FIT summary score. Results: After the implementation of COVID-19 mitigation measures, cardiorespiratory fitness and action speed decreased dramatically, and the number of children with overweight or obesity increased. At the last measurement after the COVID-19 mitigation measures (June 2022), significant improvements in cardiorespiratory fitness and weight status were observed . However, pre-COVID fitness levels were not achieved and BMI was still higher compared to Sept 2019. Interpretation: Our study showed a trend reversal, in that the negative indirect effects of the COVID-19 measures on fitness and health parameters of children were followed by significant improvements in these parameters after the removal of those mitigation measures. At the end of the observation period, a positive trend in the development of fitness and health status was observed, although pre-COVID levels were not reached. Collaborative efforts are needed to reinforce the observed positive trend, and to continue to improve the level of fitness and health status of primary school children, and to mitigate the long-term negative health consequences of the COVID-19 pandemic. Funding: Austrian Federal Ministry of Arts, Culture, Public Service and Sports (GZ2021-0.361.671).
... This occurrence, COVID-19, has exacerbated the widening gaps between those with and without in recent years. COVID-19 has worsened disparities between populations within nations (like low-income and marginalized groups) and between nations [74]. Many individuals will lack the resources essential to remain resilient in the face of this career setback. ...
Chapter
Full-text available
This chapter focuses on the exclusive and social experiences of people in post-COVID-19 life. As it can be observed from the current scenario how people have already accepted COVID-19 as a part of their daily routine. That is from wearing masks to using hand sanitizers and other precautionary activities. Based on these observable changes and adaptation of habits, the current chapter will delve into the psychological causes based on various theoretical concepts and the present literature on how humans use varied mechanisms to adapt to aversive situations and emerge by transforming themselves to be more resilient than before. Likewise, the chapter will also focus on individual and social strategies that can be employed to further strengthen the resilience of people post COVID-19.